Nucleus RadioPharma
United States
- Rochester, MN
- 18/10/2023
- Series A
- $56,000,000
Transforming lives with radiopharmaceuticals by leveraging world class clinical, development, manufacturing, and supply chain expertise. Nucleus bridges the gap between innovation and clinic.
- Industry Pharmaceutical Manufacturing
- Website https://nucleusrad.com/
- LinkedIn https://www.linkedin.com/company/nucleus-radiopharma/about/
Related People
Charles ConroyFounder
United States -
Charlotte Metro
Contact: csconroyrph@gmail.com
Skilled negotiator and decision maker with excellent leadership, problem solving and relationship building skills. Expertise includes:
• Specialty Pharmacy
• Pharmacy Operations Management
• Business Development
• Product Development and Launch
• Alliance Management
• Strategic Planning
• Market Planning
• Corporate and Product Strategy
• Team Leadership and Development
• Acquisition Integration
• Operational Improvement
Specialties: Strategic Development, Pharmaceutical Marketing, Medical Device Marketing, Contract Negotiation, Nuclear Medicine, Process Management, New Business Start-up, Acquisitions, Mergers, Divestitures, Six Sigma, Sterile Compounding, Pharmaceutical Compounding, 340B, Supply Chain, Supply Chain Management
WealthAi | $1,000,000 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)